Europe's pharma industry wants six years' drug protection for India
This article was originally published in Scrip
Executive Summary
The European pharmaceutical industry association, EFPIA, has given its clearest indication yet that it is looking for six years of data exclusivity for its products in India in the controversial EU-India free trade agreement that is expected to be finalised this year.